跳至主要内容
临床试验/KCT0004607
KCT0004607招募中未知

Aripiprazole augmentation for somatic symptoms of major depressive disorder: a randomized controlled trial

Chung-Ang Univerisity Hospital0 个研究点目标入组 52 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 65(Year)(—)
性别
All

入选标准

  • ? Age between 20 and 65 years old
  • ? Patients diagnosed with major depressive disorder not accompanied by psychotic symptoms by Structured Clinical Interview for DSM-5 (SCID-5)
  • ? 11 or more points on the SCL-90R-SOM scale, meaning accompanying significant somatic symptoms.
  • ? Those who have no history of using antipsychotics, including aripiprazole, at the time of initial evaluation
  • ? Those who are taking antidepressants at stable dose for more than 1 month

排除标准

  • ? Those who have been diagnosed with other psychiatric disorder by SCID-5-CV
  • ? People with past or present substance dependence or abuse history
  • ? A person with a history of epilepsy, head trauma, or organic mental illness

研究者

发起方
Chung-Ang Univerisity Hospital

相似试验